Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AM Rx vs LevelsRx

AM Rx
Graded #490

Lower grade

vs+16.699999999999996
LevelsRx
Graded #183

Higher grade

The verdict

LevelsRx takes it — 66.6/100 to 49.9/100.

LevelsRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. LevelsRx is a US direct-to-consumer telehealth offering compounded GLP-1 weight-loss medication, including compounded semaglutide (injectable and an oral liposomal liquid) starting at 150 dollars per month…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLevelsRx +17
51
68
Dose & formulationLevelsRx +10
65
75
Clinical oversightLevelsRx +35
41
76
Labs & monitoringLevelsRx +3
49
52
FulfillmentLevelsRx +11
58
69
Contract termsLevelsRx +21
20
41
AM Rx · left barLevelsRx · right bar

The numbers

MetricAM RxLevelsRx
WeighScore49.9/10066.6/100
GradeCC
Scorecard rank#490#183
Semaglutide$151/mo (quarterly plan, plus a separate fee, compounded)$150/mo (starting dose, compounded)
TirzepatideNot disclosed$240/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
AM Rx

Graded #490 · C

Strengths

  • Insurance coordination for brand-name GLP-1s — as low as $25/mo
  • All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • HSA and FSA accepted
  • Video visits available with providers averaging 10+ years' experience
  • Compounded semaglutide from $151/mo on the quarterly plan

Where it loses points

  • Active FTC/DOJ lawsuit over deceptive billing and subscription practices
  • Novo Nordisk false-advertising lawsuit (Aug 2025)
  • Parent company Zealthy holds a BBB D- rating with 2,370+ complaints
  • Trustpilot 2.0/5, with 85% one-star reviews citing billing disputes and unreachable support
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
LevelsRx

Graded #183 · C

Strengths

  • Both injectable and oral semaglutide plus tirzepatide, with same-day virtual visits
  • Weight-loss money-back warranty if targets are not met
  • 24-7 phone and email support with unlimited online provider visits

Where it loses points

  • Compounding pharmacy is not named publicly
  • States served are not published on the site
  • Prices are 'starting at' figures that may rise with dose

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard